Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

SBC Medical Group Holdings Incorporated (SBC) had Cost of Goods Sold of $12.71M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$43.06M
Net Income	$11.31M
Cost of Goods Sold	$12.71M
Gross Profit	$30.35M
Operating Expenses	$25.34M
Operating Income	$17.72M
Non-Operating Income/Expense	$1.14M
Pre-Tax Income	$18.86M
Normalized Pre-Tax Income	$18.86M
Income after Taxes	$11.33M
Income from Continuous Operations	$11.33M
Consolidated Net Income/Loss	$11.33M
Normalized Income after Taxes	$11.33M
EBIT	$17.72M
EBITDA	$18.39M
Weighted-Average Shares Outstanding (Basic)	102.58M
Weighted-Average Shares Outstanding (Diluted)	102.58M
Earnings per Share (EPS) (Basic)	$0.11
Earnings per Share (EPS) (Diluted)	$0.11
Balance Sheet Financials
Current Assets	$238.78M
Property, Plant, and Equipment	$7.29M
Long-Term Assets	$149.24M
Total Assets	$388.02M
Current Liabilities	$62.57M
Long-Term Debt	$31.54M
Long-Term Liabilities	$55.07M
Total Liabilities	$117.64M
Common Equity	$270.38M
Tangible Shareholders Equity	$207.83M
Shareholders Equity	$270.38M
Common Shares Outstanding	102.58M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.23M
Cash Flow from Investing Activities	$-0.53M
Cash Flow from Financial Activities	$-1.84M
Beginning Cash	$163.77M
End Cash	$167.31M
Increase/Decrease in Cash	$3.53M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.82
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.10
Debt to Equity Ratio	0.15
Gross Margin	70.47%
Operating Margin	41.15%
EBIT Margin	41.15%
EBITDA Margin	--
Pre-Tax Profit Margin	43.79%
Profit Margin	26.26%
Free Cash Flow	$8.68M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	5.47
Receiveable Turnover	0.97
Days Sales in Receivables	93.21
Return on Equity	4.19%
Return on Tangible Equity	5.45%
Return on Assets	2.92%
Return on Investments	3.75%
Book Value Per Share	$2.64
Free Cash Flow per Share	$0.08
Operating Cash Flow per Share	$0.09

Data from Zacks Investment Research, Inc.